The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) under the Federal Supply Schedule (FSS) contract V797P-7322A to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer. This single-award BPA, valued at $177,780.31, will enable the VA's Veterans Integrated Service Network 2 (VISN 2) to procure Abbott's i-STAT Troponin Multipurpose Point of Care Testing equipment, supplies, and related services on a cost-per-test basis. The contract has a period of performance from October 1, 2024 to September 30, 2025.
This BPA was awarded following a Special Notice issued by the VA, which indicated their intent to award a sole source contract to Abbott for the required point-of-care testing services, including blood gases, chemistries, coagulation, cardiac markers, hematology, and endocrinology testing. The VA is allowing interested parties to submit expressions of interest by July 12, 2024 to determine if a competitive procurement may be warranted. This contract supports the VA's VISN 2 Pathology and Laboratory Medicine Services in providing critical diagnostic testing capabilities to veterans across the region.
Generated 9/7/24, 10:23 AM